NQO1 is increased in AD and, as memoquin is specifically reduced by this enzyme into the respective hydroquinone, it is possible that memoquin exerts its antioxidant activity specifically in brain regions affected by AD [103]. The gene discussed is NQO1; the disease is Alzheimer disease.